The deregulation of Cdk5, particularly hyperactivation, is implicated in several psychiatric disorders and neurodegenerative diseases characterized by severely impaired cognitive functions12, 13, 19; accordingly, the inhibition of Cdk5 activity can alleviate the synaptic losses and cognitive impairments in certain pathological conditions51, 52. This evidence concerns the gene CDK5 and neurodegenerative disease.